Bowen Hanes & CO Inc Gsk PLC Transaction History

Bowen Hanes & CO Inc

$3.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $123,626 - $140,443	2,940 Added 55.75%	8,214 $364,000
Q2 2021 Aug 12, 2021	SELL	$36.52 - $41.46 $122,342 - $138,891	-3,350 Reduced 38.85%	5,274 $210,000
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $850,067 - $992,448	-24,805 Reduced 74.2%	8,624 $308,000
Q4 2020 Feb 08, 2021	BUY	$34.07 - $39.94 $171,031 - $200,498	5,020 Added 17.67%	33,429 $1.23 Million
Q3 2020 Feb 08, 2021	SELL	$38.11 - $42.99 $38 - $42	-1 Reduced -0.0%	28,409 $1.07 Million
Q3 2020 Nov 02, 2020	SELL	$38.11 - $42.99 $2.66 Million - $3 Million	-69,680 Reduced 71.04%	28,410 $1.07 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $1.01 Million - $1.17 Million	-26,735 Reduced 21.42%	98,090 $4 Million
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $32,470 - $48,830	-1,000 Reduced 0.79%	124,825 $4.73 Million
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $34.2 Million - $39.3 Million	-813,735 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $1.66 Million - $1.78 Million	40,970 Added 5.3%	813,735 $34.7 Million
Q2 2019 Aug 13, 2019	BUY	$39.4 - $42.7 $2.67 Million - $2.89 Million	67,675 Added 9.6%	772,765 $30.9 Million
Q1 2019 May 13, 2019	BUY	$38.57 - $42.69 $8.89 Million - $9.84 Million	230,400 Added 48.54%	705,090 $29.5 Million
Q4 2018 Feb 13, 2019	BUY	$37.8 - $42.69 $17.5 Million - $19.7 Million	461,850 Added 3596.96%	474,690 $18.1 Million
Q3 2018 Nov 08, 2018	SELL	$39.75 - $42.69 $25,281 - $27,150	-636 Reduced 4.72%	12,840 $516,000
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $3,406 - $3,677	86 Added 0.64%	13,476 $543,000
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $215,326 - $255,296	-6,093 Reduced 31.27%	13,390 $475,000
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $768,409 - $809,518	19,483	19,483 $791,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.

Account